Coagulation Flashcards
What happens when MTHFR decreases?
Homocystine increases
Steps of hemostasis
Primary hemostasis
Secondary hemostasis
Fibrinolysis
Steps in primary hemostasis
Vasoconstriction
Platelet adhesion
Platelet aggregation - to form primary hemostatic plug at injury site
Steps of secondary hemostasis
- Interaction of coag factors to produce fibrin (secondary hemostatic plug)
- Fibrin stabilization by FXIII
Steps in fibrinolysis
- Release tissue plasminogen activator
- Plasminogen —> plasmin
- Fibrin —> fibrin degradation products
What are the quantitative plt disorders?
Thrombocytopenia
Primary thrombocytosis
Secondary or reactive thrombocytosis
Thrombocytopenia
Decrease production, increase destruction
<30x10^9/L: petechiae, menorrhagia, spontaneous bruising
<10x10^9/L: severe spontaneous bleeding
Lab tests: Plt <150 x 10^9/L
Primary thrombocytosis
Unregulated production of megakaryocytes in BM (like ET)
Thrombosis (blood clots) or hemorrhage (damaged blood vessel)
Lab tests: >1000 x 10^9/L
Secondary or reactive thrombocytosis
Increased plt due to another condition (like hemorrhage, surgery, splenectomy)
No thrombosis or hemorrhage
Lab tests: 450-1000 x 10^9/L
Qualitative Platelet Disorders
Inherited: Bernard-Soulier syndrome, Glanzmann’s thrombasthenia, delta-storage pool disorder
Acquired
Bernard-Soulier syndrome
Lack of GP Ib/IX/V on plt surface —> no plt interaction w/ VWF —> abnormal adhesion to collagen
Glanzmann’s thrombasthenia
Deficiency or abnormality of plt membrane GP IIb/IIIa —> fibrinogen can’t attach to plt surface —> cannot do plt aggregation
delta-storage pool disorder
Dense granule deficiency —> no ADP released —> abnormal secondary aggregation with ADP & epinephrin
Acquired plt disorder
Functional plt disorder (occurs with renal failure, aspirin, etc) —> abnormal plt aggregation
Tests for platelet function
Platelet aggregation
Platelet function assay (PFA)
VWF:Ag
Platelet aggregation (plt function test)
Aggregating agent (ADP, collagen, ristocetin, epinephrine) added to plt suspension
Time it takes for plts to aggregate = increase in light transmittance
Curve = time vs % transmittance
Platelet function assay (PFA) - plt function test
Citrated WB in a capillary tube coated with ADP/collagen or epinephrine/collagen
Plts adhere and aggregate when exposed to collagen
Closure time = time it takes for plts to form a plt plug and close aperture of capillary tube
VWF:Ag
Immunologic test (ex: EIA) using monoclonal Abs to VWF
VWF needed for plts to connect to collagen (plts don’t function properly if decreased VWF — like in VWD)
Factor I
Fibrinogen
Fibrinogen —thrombin—> fibrin
Factor II
Prothrombin
Prothrombin —> thrombin
Factor III
Tissue factor (in extrinsic pathway)
Factor IV
Ca2+
With 8a and 5a
Factor V
Labile factor (proaccelerin)
Factor VII
Stable factor (proconvertin)
Factor VIII
Antihemophilic factor
Deficiency = Hemophilia A
FVIII + VWF
Factor IX
Christmas factor
Deficiency: Hemophilia B
Factor X
Stuart factor
Factor XI
Plasma thromboplastin antecedent
Deficiency: Hemophilia C (rare) - may or may not cause bleeding
Factor XII
Hageman factor (contact factor)
Deficiency: no bleeding
Factor XIII
Fibrin stabilizing factor (stabilizes fibrin clot)
HMWK (high molecular weight kininogen) + PK (prekallikrein)
Fitzgerald factor & Fletcher factor, respectively
Used with (F12 and F11) to activate the intrinsic pathway
What is a substrate? And what is the factor?
Substance changed by an enzyme
Factor: fibrinogen (F1)
What is a cofactor? And factors associated?
Protein that accelerates enzymatic reactions
Factors: 5 (cofactor for 10a) and 8 (cofactor for 9a)
What is an enzyme? And factors associated?
Protein that catalyzes a change in specific substrate
Serine proteases: 2a (thrombin), 7a, 9a, 10a, 11a, 12a, prekallikrein (PK) — (1972 + 11 + 12)
Transglutaminase: XIIIa
Contact group
Factors involved in initiation of intrinsic pathway
HMWK, PK, F12, F11
Prothrombin group
Vitamin K dependent factors
1972 (10, 9, 7, 2)
Fibrinogen group
Factors acted on by thrombin
1, 13, 5,
Consumed in clotting (not in serum)
Increased in acute phase (pregnancy and inflammation)
Extrinsic pathway factors
TF (F3) & F7
Intrinsic pathway factors
F12, 11, 9, 8, HWMK, PK
Common pathway factors
1, 2, 5, 10
Extrinsic tenase complex
VIIa/TF
Acts on X
Intrinsic tenase complex
9a/8a
Acts on X
Prothrombinase complex
10a/5a
Acts on prothrombin
Factor VIII complex
FVIII:C & VWF
VIII:C = procoagulant
VWF = carrier protein
All factors are produced in what organ?
Liver
What factors are affected by coumadin/warfarin?
Factors that need Vitamin K (1972)
What factors are consumed during clotting?
1, 13, 5, 8, 2 (basically all of the fibrinogen group ones + 2)
Labile factors
5, 8
INR (international normalized ratio)
[patient PT/mean normal PT]^ISI
Aspirin
Platelet inhibitor
Destroys cyclo-oxygenase —> inhibits plt release
Clopidogrel (Plavix)
Plt inhibitor
Blocks ADP receptor (P2Y12) — prevents plt aggregation
Eptifibatan, Abciximab, Tirofiban (EAT)
(Plt inhibitor)
GP IIb/IIIa receptor inhibitor
Warfarin
Inhibits Vit K (1972)
Requires monitoring with PT/INR
Eliminated by liver
Dabigatran
Thrombin inhibitor
Eliminated by kidneys
Rivaroxaban & Apixaban
Factor Xa inhibitor
Heparin (unfractionated)
Inhibits active serine protease factors via anti-thrombin
Monitor with anti-Xa assay
Low Molecular Weight Heparin (LMWH)
Targets Factor Xa & 11a
Monitor with anti-Xa assay
Zymogens
Inactive coagulation forms (like XII before it becomes XIIa)
Acquired hemophilia vs inherited hemophilia
Acquired: inhibitor
Inherited: deficiency
Defective clot retraction caused by
Defect in GP IIb/IIIa